Atlas Trials

Modifications of Immune Microenvironment Induced by Neoadjuvant Chemotherapy in Triple-negative BC

Clinical trial NCT04368468 · COMPLETED

Trial details

NCT number
NCT04368468
Sponsor
Institut Claudius Regaud
Status
COMPLETED
Study type
OBSERVATIONAL
Triple Negative Breast Cancer
Start date
2020-06-15
Primary completion
2020-12-15
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.